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1. Introduction
The success of any implant depends so much on the biomaterial used. Naturally derived
biomaterials have been demonstrated to show several advantages compared to synthetic
biomaterials. These are biocompatibility, biodegradability and remodeling. Therefore, these
biomaterials are usually applied in the repair or replacement of damaged human tissues and
organs. The aim of this chapter is to provide a brief knowledge of naturally derived biomate‐
rials as well as methods of preparation and application of them.
Biomaterials can be classified into two main groups: synthetic and natural biomaterials.
Synthetic biomaterials are classified as: metals, ceramics, nonbiodegradable polymers,
biodegradable polymers… Some synthetic biomaterials are commercialized and applied in
clinical treatment such as metal hip, Dacron, plastic intraocular lens… However, synthetic
biomaterials have some disadvantages, including their structure and composition is not similar
to native tissues/organs, their biocompatibility and their ability to induce tissue remodeling
are low. Thus, other biomaterials have been developed that can overcome the disadvantages
of synthetic biomaterials. Today, naturally derived biomaterials have been attracting scientist’s
interest all over the world. Naturally derived biomaterial can be classified into many groups
including protein-based biomaterials (collagen, gelatin, silk…), polysaccharide-based bioma‐
terials (cellulose, chitin/chitosan, glucose…) and decellularized tissue-derived biomaterials
(decellularized heart valves, blood vessels, liver…). Protein and polysaccharide-based
biomaterials can be prepared by two distinct ways. Protein and polysaccharide from living
organisms are dissolved by solvents or enzymes. Then, they are precipitated and reconstituted
into fibrils. The second way to prepare protein and polysaccharide is removing other elements
of living organisms by solvents or enzymes. Decellularized biomaterials are created by
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eliminating all cells from native tissues/organs. Physical, chemical and enzymatic approaches
are combined to make the effective decellularization protocol.
Because of their advantages, naturally derived biomaterials are usually applied to replace or
restore structure and function of damaged tissues/organs. They have ability to adequately
support cell adhesion, migration, proliferation and differentiation. In particular, when
implanted into a defective area, naturally derived biomaterials can enhance the attachment
and migration of cells from the surrounding environment, therefore, induce extracellular
matrix formation and promote tissue repair. Some biomaterials are used to acting as drug
delivery system and medical devices such as surgical sutures. The silk fiber produced by
silkworm or spider has been used as a surgical suture for a long time due to its biodegradable
and non-antigenic protein. These silk fibroin nanoparticles are the globules with a fine
crystallinity that may offer various possibilities for surface modification and covalent drug
attachment. Furthermore, some biomaterials are used to produce environmental friendliness
of packaging (such as resorbable chitosan packing) and other products. Some commercial
products were made from naturally derived biomaterial such as SIS, Matrigel, Alloderm… In
this chapter, we focus on a brief knowledge as well as the methods of preparation and
application of naturally derived biomaterials in our researches.
2. Naturally derived biomaterials: Preparation and application
2.1. Protein
2.1.1. Collagen
2.1.1.1. Structure
Collagen is the most abundant protein of connective tissues in all animals. Now, at least sixteen
types of collagen have been identified, in which 80-90% of the collagen is types I, II and III.
Collagen is secreted by not only fibroblasts but also epithelial cells [1].
The basic structural unit of collagen is a triple helix. Most collagen is fibrillar because of pack
of collagen molecules type I, II, III. Contrast, collagen IV forms a two dimensional network
which is unique to the basement membranes [1]. Basement membranes have been performed
a number of mechanical and biological functions. They provide physical support for tissue
because of their tensile strength. They also influence cell proliferation, adhesion, migration,
differentiation, polarization, and are thus implicated in biological processes such as develop‐
ment, tissue maintenance, regeneration, and repair, and in various pathological processes such
as tumor growth and metastasis [2].
The basement membranes composition varies from one tissue to another. In general, the major
constituents of all basement membranes are collagen IV, laminins, nidogen/entactin, and
proteoglycans. The functional diversity of basement membranes arises from the molecular
diversity of their components, particularly the different collagen IV and laminin isoforms [2].
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2.1.1.2. Preparation
Collagen can be obtained from various sources, in which amniotic membrane (AM) is an
attractive source. AM is a thin membrane surrounding the fetus which is filled with amniotic
fluid.
The AM consists of an epithelial monolayer, a thick basement membrane, a compact layer, a
fibroblast layer and a spongy layer [3]. The innermost layer, nearest to the fetus, is monolayer
of epithelial cells anchored on the basement membrane. The collagen component of basement
membrane of AM includes types III, IV, V, VII, XVII which similar morphological and ultra-
structural basement membrane of skin. Therefore, basement membrane of AM is often used
to create skin equivalents. Besides, AM has outstanding properties such as anti-inflammatory,
anti-bacterial, anti-fibrosis, anti-scaring as well as low immunogenicity and reasonable
mechanical features [3].
AM can be used either with amniotic epithelium (intact) or without it (denuded), fresh or
preserved. To remove the amniotic epithelium, the AM is incubated in trypsin-EDTA at 37oC
in 30 min and the cells are gently scraped while maintaining the intact basement membrane.
H&E staining was performed to confirm removing the amniotic epithelium. Then, the
basement membrane can be preserved by drying or glycerol - cryopreservation after γ-
sterilization [3, 4, 5].
2.1.1.3. Application
Collagen is commonly used in biomedical applications. The basement membrane of the AM
is a typical example. The extracellular matrix components of the basement membrane of the
AM are native scaffolds for cell seeding in tissue engineering. AM has been applied in tissue
engineering related to eye, skin, cartilage, nerve, especially cancer [3, 6, 7].
 
a b 
Figure 1. Amniotic membrane with epithelium: intact (a) and denuded (b)
To use AM in creating skin equivalent, AM must be removed the epithelium. Keratinocytes
are seeded onto basement membrane which is denuded AM. Briefly, keratinocytes were iso‐
lated from intact skin samples by incubation in trypsin-EDTA at 40C in 18 hours and detach‐
ed mechanically. Keratinocytes were cultured in serum free medium in 7 days. Medium was
chanced every two days [8]. After 3rd passage, cells were subcultured onto AM basement
membrane which spreaded on bottom of the insert dishes. The cells were maintained in cul‐
ture for 7 days when the cells reached confluent. Air-lifting was performed to induce cell
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differentiation. After 7 days, the cells formed multi-layers on the AM basement membrane.
Cultured keratinocyte sheets were grafted on patients who were defected skin because of in‐
jury or burn. The result showed that, the advantages of cultured keratinocyte sheet auto‐
graft: the possibility of the grafting area multiplication (50 times after 3 weeks), the
diminution of scaring, the relief of pain, the low infection risk, the same effect in compare to
the split - thinness autograft.
 
b a 
Figure 2. Keratinocytes formed colonies (a) and monolayer onto culture dishes (b) (200X)
Figure 3. Result of HE staining of the cell sheet, the cells were exposed to the air in seven days. The cells formed 4 – 5
layers onto AM basement membrane (400X).
2.2. Gelatin-Alginate
2.2.1. Structure
Gelatin is obtained by controlling the hydrolysis of collagen, a fibrous insoluble protein which
is widely found in nature and is the major component of skin, bone and connective tissue.
Characteristic features of gelatin are the high content of the amino acids such as glycine, proline
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and hydroxyproline. Structually, gelatin molecules contain repeating sequences of glycine-X-
Y triplets, where X and Y are frequently proline and hydroxyproline. These sequences are
responsible for the triple helical structure of gelatin and its ability to form gels where helical
regions form in the gelatin protein chains immobilizing water [9].
Alginate was first discovered by Edward Stanford in 1883. Since being commercialized in 1927,
alginate has now expanded to about 50.000 tonnes per year worldwide; 30% of this tonnage is
devoted to the food industry, the rest being used in industrial, pharmaceutical and dental
applications [10]. The function of alginates in algae is primarily skeletal, with the gel located
in the cell wall and intercellular matrix conferring the strength and flexibility necessary to
withstand the force of water in which the seaweed grows [11].
Alginate is a hydrophilic polysaccharide extracted from marine brown algae such as Laminaria
hyperborea or soil bacteria such as Azobacter vinelandii and composed of 1,4-linked β-D-
mannuronic acid (M) residues and 1,4-linked α-L-guluronic acid (G) in varying proportions,
displaying carboxylic acid functionality at the C5 residue. The alginates have broad distribu‐
tions of molecular weights of 10-1000 kDa depending on source and processing. The relative
amount and sequential distribution of homogeneous M-M segments (M-blocks), homogene‐
ous G-G segments (G-blocks) and alternating M-G segments (MG-blocks), which represent the
primary structure of alginate, depend on the producing species, and for marine sources, on
seasonal and geographical variations.
2.2.2. Preparation
Cross-linked gelatin/alginate was made in two steps. Briefly, 1wt % (w/w) aqueous solution
of gelatin and sodium alginate, respectively, was dissolved in double distilled water at 500C
for 3 h. Each solution with certain mixing ratios of gelatin and sodium alginate (8G:2A) was
stirred for 30min at room temperature, frozen to -700C for 40 h. This soluble sponge was cross-
linked with EDC by immersing the soluble sponge in 90% (w/v) aqueous acetone containing
0.3% EDC for 24 h at room temperature, while shaking slowly.
a b
Figure 4. Gelatin-Alginate. Block (a), SEM (b)
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The sponges consisting of gelatin from hydrolysis of collagen and alginate-a polysaccharide
from Phaeophyta were established by using EDC as a crosslinking agent. The sponges were
combined with some natural substances traditional used for burn treatment such as tamanu oil
(from nuts of Calophyllum inophyllum); cajeputi oil (from leaves of Meulaleuca leucaden‐
dron); madecassol (from extract of Centella asiatica); turmeric and python fat. Data obtained
from testing on mice showed that the coordinated sponges have rather good ability on pre‐
venting infection and promoting wound healing compared with control. The sponges com‐
bined with mixture of cajeputi oil and madecassol have the best potential for burn treatment.
2.2.3. Application
Gelatin has been used in medicine as plasma expander, wound dressing, adhesive, and
absorbent pad for surgical use. While collagen, also known to have wide biomedical applica‐
tions, expresses antigenicity in physiological condition, gelatin is known to have no such
antigenicity. Recently, gelatin has shown to exhibit activation of macrophages and high
hemostatic effect. Finally, gelatin is practically more convenient than collagen because a
concentrated collagen solution is extremely difficult to prepare from the native collagen, and
furthermore gelatin is far more economical than the collagen.
Alginate is an effective natural disintegrant, tablet binder and offers an attractive alternative
for sustained-release systems. It offers advantages over synthetic polymers as it forms
hydrogels under relatively mild pH and temperature and is generally regarded as non-toxic,
biocompatible, biodegradable, less expensive and abundantly available in nature; in addition,
alginate meets the important requirement of being amenable to sterilization and storage. All
these advantages make alginates very useful materials for biomedical applications, especially
for controlled delivery of drugs and other biologically active compounds and for the encap‐
sulation of cells. Calcium alginate is a natural haemostat, so alginate based dressings are
indicated for bleeding wounds. The gel forming property of alginate helps in removing the
dressing without much trauma [12].
Alginate has been much used in medical applications such as wound dressings, scaffolds for
hepatocyte culture and surgical or dental impression materials. Alginates are also known to
be broken down to simpler glucose type residues and can be totally absorbed.
Alginate has been successfully used as a matrix for the entrapment and/or delivery of biological
agents, such as drugs and proteins. In particular proteins can be loaded and released by
alginate matrices without loss of their biological activity because of the relatively mild gelation
process of alginate. In pharmaceutical formulations, the alginate gel can be prepared prior to
use, or it can spontaneously form in situ in physiological fluids, by low pH and/or calcium
ions naturally present in the site of administration [13]. Alternatively, the gelling agent can be
added either as a part of the formulation or separately administered. The microencapsulation
technique has been specifically developed for the oral delivery of proteins, as they are quickly
denaturated and degraded in the hostile environment of the stomach.
Among the possible applications of alginate, one of the most promising is for cell immobi‐
lization.  Alginate gel  allows cell  suspension to be cultivated in several  types of bioreac‐
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tors  to  achieve  high  cell  densities  [14].  In  cell  immobilization  applications,  the  main
drawback of alginate matrix gels is represented by their high density of network, which
limits the cell growth; moreover, cell anchorage, a strict requirement for survival, is limited
on alginate gels, because of its hydrophilic nature. PEG copolymers are used to improve
their biocompatibility [15].
2.3. Silk
Silks are generally defined as protein polymers that are spun into fibers by Lepidoptera
larvae  such as  silkworms,  spiders,  scorpions,  mites  and flies  [16].  Silks  are  fibrous  pro‐
teins  synthesized in  specialized epithelial  cells  that  line  glands  in  these  organisms.  Silk
fibroin  polymers  consist  of  repetitive  protein  sequences  and  provide  structural  roles  in
cocoon formation, nest building, traps, web formation, safety lines and egg protection. The
most extensively used silk for various applications are those from silkworm silk; Bombyx
mori and spider silk; Nephila clavipes.
The domesticated silkworm (B. mori) silk fibroin fibers are about 10–25 μm in diameter. Each
fiber consists of core protein covered by a coating protein (sericin) that glues core fibers
together. The core protein consists of three chains: heavy chain, light chain and a glycoprotein,
P25. The light chain (26 kDa) and heavy chain (390 kDa) which are present in a 1:1 ratio and
linked by a single disulfide bond. The disulfide linkage between the Cys-c20 (20th residue from
the carboxyl terminus) of the heavy chain and Cys-172 of the light chain holds the fibroin
together and a 25 kDa glycoprotein, named P25, is non-covalently linked to these proteins [17].
Light chain is necessary for the secretion of protein from the silk glands. Heavy chain is fiber
forming protein and its structure determines properties of silk fiber [18]. Heavy chain is
commonly referred as fibroin protein. These proteins are coated with a family of hydrophilic
proteins called sericins (20–310 kDa). Silk proteins are particularly promising for these needs
due to their unique combination of biocompatibility, biodegradability, self-assembly, me‐
chanical stability, controllable structure and morphology.
Spiders are look like insects and come in to the category of Arthropoda, but they belong to a
completely different class of animals, called Arachnida. Spider silk is the result of 400 million
years of evolution. Spiders use silk for variety of functions including reproduction as cocoon
capsular structures, lines for prey capture, lifeline support (dragline), web construction and
adhesion. Spider silk is a biopolymer fiber. Its composition is a mix of an amorphous polymer
(which makes the fiber elastic), and chains of two of the simplest proteins (which give it
toughness). Out of 20 amino acids, only Glycine and Alanine serve as a primary constituent
of silk. The Dragline silk of orbweb spider seems to be most studied in the scientific research.
The protein in dragline silk is fibroin (Mass of 200,000-300,000 Daltons) which is a combination
of the proteins spidroin 1 (Alanine-rich) and spidroin 2 (Glycine-rich), the exact composition
of these proteins depends on species. Fibroin consists of approximately 40% Glycine and 25%
Alanine as the major amino acids. The remaining components are mostly glutamine, serine,
leucine, valine, proline, tyrosine and arginine [19]. Nephila clavipes can produce seven types
of silk from seven different silk glands as shown in depending on needs and environmental
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conditions [20]. The superior mechanical properties of dragline spider silks can be used as a
template for developing specific structures for various biomaterial needs. Spider silks have not
been commercialized in fashion as silkworm silk due to the lack of domestication and lower
productivity of spiders.
2.3.1. Preparation
Nanotechnology is becoming a key technology and capable of application in all fields of science
and technology. In particular, nanoparticle delivery system significantly improved pharma‐
ceutical treatment of many incurable diseases which require complex treatment regimens, as
well as, patients must take multiple medications and need time long-term drug use. Silk
Protein is the ideal material for this purpose, because they have many unique features such as
highly biocompatible and biodegradable ability, self-restructuring, mechanical stability, easy
control and adjustment of the object's structure and shape.
 
Figure 5. Nanofibroin particles
The cocoon shell of silkworm Bombyx mori was degummed in boiling solution of 0,5%
Na2CO3 in 700C for 35 min. Then degummed fiber was dissolved in a mixed solution of
calcium chloride, ethanol, and water (CaCl2/C2H5OH/H2O: 1:2:8 mole ratio), at 800C. After
the silk fibroin–salts solution was centrifuged at 5000 rpm for 10 min, the supernatant was
dialyzed continuously for 72 h against running pure water to remove CaCl2, smaller mole‐
cules, and some impurities. The resulting liquid silk fibroin was stored at 40C and used in the
following experiments for the preparation of silk fibroin nanoparticles. Spider silk proteins
form nanoparticles upon salting out with potassium phosphate. Milk-like silk protein particles
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were formed at once and suspended in the mixture comprising water and organic solvent.
These protein particles were water insoluble and went down slowly due to the gathering of
microparticles. The precipitates of silk protein nanoparticles were collected and purified from
the mixture by repeated centrifugation at 20,000 rpm to separate these particles from the
solvent. After the research, we have obtained nanoparticles (500 nm-2000 nm) from silk protein
can load and delivery of proteins in vitro.
2.3.2. Application
The silk bio-polymer is used in tissue regeneration for treating burn victims and as matrix of
wound healing. The silk fibroin peptides are used in cosmetics due to their glossy, flexible,
elastic coating power, easy spreading and adhesion characters [21]. Silk powder is touted and
relieves from sunburns, due to crystalline structure it reflects UV radiation and as demulcent
it acts as protective buffer between skin and environment. The lower micron silk powder is
added with hair and massage oils and water dispersible finer grade silk powder is an ingre‐
dient of liquid cosmetic preparations.
The silk is used to fight edema, cystitis, impotence, adenosine augmentation therapy, epidi‐
dymitis and cancer [22]. Silk protein derivative, Serratio peptidase is used as anti-inflamma‐
tory, anti-tumefacient for treating acute sinusitis, tonsiloctomy, oral surgery, tooth filling,
cleaning and extractions. The silk fibroin is a useful dressing material with the property of non-
cytotoxic to the tissues and also in veterinary medication.
Since long, silk fiber is being used as surgical sutures as it does not cause inflammatory
reactions and is absorbed after wounds heal. Other promising medical applications are as
biodegradable micro tubes for repair of blood vessels and as molded inserts for bone, cartilage
and teeth reconstruction [23, 24, 25]. In biomedical and bioengineered field, the use of natural
fibre mixed with biodegradable and bio-resorbable polymers can produce joints and bone
fixtures to alleviate pain for patients.
Drug delivery is a rapidly developing field in biomedical research. It is interdisciplinary and
requires expertise in biotechnology, pharmacology, microbiology, biochemistry, polymer
chemistry and materials engineering. Advantages of using such systems include maintenance
of drug levels within desired range, fewer administrations, optimal use of the drug, and better
patient compliance. The material used for drug delivery should be biocompatible, chemically
inert, easily processable and physically and mechanically stable. Biopolymers are of great
interest for this kind of application. Silk and silk-like variants are used by some scientists as
carriers for drug delivery. Their biocompatibility and ability to form hydrogels in situ makes
them attractive candidates for the localized, controlled delivery of therapeutic agents. Their
ability to incorporate drugs at room temperature, by simple mixing, and without the use of
toxic or denaturing solvents makes them attractive for the delivery of protein or DNA-based
therapies [26].
Future applications of silk biomaterials include new generation soft contact lenses that enable
greater oxygen permeability, artificial corneas, skin grafts and epilepsy drug permeable
devices.
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2.4. Fibrin
2.4.1. Structure
The mechanism of fibrin fomation is elucidated primarily from the thrombin-mediated
cleavage of fibrinogen. Fibrinogen, the principal protein of blood clotting, is a 340 kDa trinolar
protein which presents at high concentration in blood plasma (2 – 4 mg/ml, 6 – 12 μM).
Fibrinogen molecule consists of three different pairs of polypeptide chains (Aα, Bβ and γ)
cross-linked to each other by 29 disulfide bridges (Fig. 1). The amine-termini (N-termini) of six
polypeptide chains are converged in the central of fibrinogen molecule called the E domain.
The carboxy-termini (C-termini) of the Bβ chain and γ chain comprise of the distal D domain.
The C-termini of Aα chains which are known as globular, depart from the D domain and fold
into a conformation that stretches back toward the E domain of fibrinogen [27].
Fibrinogen plays as precursor protein of fibrin in blood clotting. The conversion of fibrinogen
to fibrin occurs in 3 ordered steps. In the intinial step, thrombin binds to the central E domain
of fibrinogen and slipts off the fibrinopeptides A – FpA (16 amino acid residues) and B – FpB
(14 amino acid residues) from N-termini of Aα and Bβ chains, respectively, whereas the γ
chains remain unaltered. The cleavage of FpA and FpB results in exposure of “A” and “B”
binding sites. Then, the self-assembly proccess will spontaneously occur. The “A” and “B”
sites will interact with complementary sites (“a” and “b” sites located in the γ and β chain) at
the D domain of other fibrinogen molecules, which results in new fibrin monomers. The fibrin
monomers are bound to each other non-covalently (Fig. 2) and assemble in a half-staggered
manner into two-stranded protofibrils which continue to aggregate laterally to form fibers
branching into a three-dimensional network of fibrin [28, 29]. Finally, fibrin cross-linking is
activated by Factor XIII (FXIII) in order to improve the strong and elastic properties, addi‐
tionally, avoid fibrinolysis in solution [30, 31].
2.4.2. Fabrication of fibrin gel
According to the usage purposes, some methods have been applied to fabricate fibrin gels.
Fibrin gels can be conducted either from the separating components including thrombin,
fibrinogen and CaCl2, or from serum of patients, which will be mentioned in two following
methods, respectively. For manipulation of fibrin gel from separating commercial compo‐
nents, fibrin gels were prepared by combining fibrinogen, NaCl, thrombin, CaCl2. This
complex is also supplemented with aprotinin in order to proving a stable fibrin structure and
prevents postoperative bleeding. The contents are allowed to gel for 1 hr in standard culture
conditions [32]. Furthermore, fibrin gel physical properties can be manipulated by adjusting
the fibrinogen and CaCl2 concentration [33, 34], or using different cross linking agents such as
enzymes or UV radiation [35]. In terms of autologous fibrin glue, the patient blood is havested
and prepared 3 to 4 days before surgery. The plasma is separated from red blood cells by
allowing the blood tube to stand vertically for at least 2 hours or centrifuged at 4000 rmp for
5 minutes. The fibrin gel preparation is created by combining plasma with commercial
thrombin and calcium at appropriate concentration [36]. Autologous plasma fibrin gel not only
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shows an excellent hemostatic agent, but also helps eliminate the risk of viral transmission
associated using donor plasma.
2.4.3. Fibrin gel applications
Numerous studies have exploited fibrin function as heamostatic plug, scaffold for cell
proliferation and migration, and wound healing, which suggest fibrin potential applications
in medical and tissue engineering. Fibrin glue or fibrin sealant is a formulation of fibrinogen
and thrombin at very high amounts cobined with calcium and FXIII, used as an adjunct to
hemostasis in patients undergoing surgery. Commercial products of fibrin sealant such as
Tisseel (Immuno, Vienna, Austria), Beriplast (Behringwerke AG, Marburg/Lahn, FRG), and
Biocol (CRTS, Lille, France) have been extensively used in clinical. In addition to fibrin’role in
heamostatic, fibrin is also indicated as biological scaffold for cell proliferation, migration and
differentiation applied in various tissue engineering. Natural fibrin matrix consists of sites for
cellular binding, and has been shown to have excellent effects in cell culture and accelabrate
tissue regeneration. In 2000, Ye et al. fabricated and investigated the three-dimensional fibrin
scaffold in cardiovascular tissue engineering. In this research, human myofibroblasts (MFBs)
from the ascending aorta were cultured in fibrin gel solution. Consequently, the cell growth,
high collagen secretation and tissue development were determined. Besides, toxic degradation
or inflammatory reactions was not detected in the fibrin gels [37]. In 2003, W. Bensa.ıd and
colleagues conducted a research in which they use fibrin glue as a delivery system for human
MSCs (HMSCs). The result confirmed a good good HMSCs spreading and proliferation in the
fibrin scaffold. Besides, the HMSCs migration out of the fibrin scaffold and appearance of
calcium carbonate from the differentiation of HMSCs when implanted in vivo suggest that
fibrin gel is a promising delivery system for HMSCs toward bone healing application [38].
Fibrin glue also performs its role in the application of skin grafts to burned areas. Using fibrin
glue instead of sutures or pressure dressings in the immediate postoperative period enhances
healing, and minimizes scarring [39]. One of commercial fibrin sealant products used for burn
treatment is ARTISS fibrin sealant (Baxter International Inc., USA). ARTISS fibrin sealant is
indicated to adhere autologous skin grafts to surgically prepared wound beds resulting from
burns, for both adults and pedipatients.
3. Polysaccharide
3.1. Cellulose
3.1.1. Structure
Cellulose is the most abundant polymer on Earth, which makes it also the most common
organic compound. Annual cellulose synthesis by plants is close to 1012 tons. Plants contain
approximately 33% cellulose whereas wood contains around 50% and cotton contains 90%.
Most of the cellulose is utilised as a raw material in paper production. This equates to approx‐
imately 108 tons of pulp produced annually. From this, only 4 million tons are used for further
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chemical processing annually. It is quite clear from these values that only a very small fraction
of cellulose is used for the production of commodity materials and chemicals [40]. Cellulose,
a linear polysaccharide of up to 15,000 D-glucose residues linked by β-(1→4)-glycosidic bonds,
is biocompatible and has excellent thermal, mechanical properties. It is considered easily
biodegradable, thus less contaminating to the environment.
Cellulose is regarded as a semi-flexible polymer. The relative stiffness and rigidity of the
cellulose molecule is mainly due to the intramolecular hydrogen bonding. This property is
reflected in its high viscosity in solution, a high tendency to crystallise, and its ability to form
fibrillar strands. The chain stiffness property is further favoured by the β-glucosidic linkage
that bestows the linear form of the chain. The chair conformation of the pyranose ring also
contributes to chain stiffness. This is in contrast to the α-glucosidic bonds of starch [41].
Plants are an attractive cellulose source primarily because they are abundant and there is a
preexisting infrastructure in the textile industries for harvesting, retting/pulping (i.e. to treat
and isolate micron sized cellulose particles), and product processing. Tunicates are the only
animals known to produce cellulose microfibrils. Tunicates are a family of sea animals that
have a mantle consisting of cellulose microfibrils embedded in a protein matrix. It is this thick
leathery mantle in their mature phase that is used as a source of cellulose microfibrils. Most
research has used a class of Tunicates that are commonly known as ‘‘sea squirts’’ (Ascidiacea),
marine invertebrate filter feeders. Several algae species such as green, gray, red, yellow-
green… produce cellulose microfibrils in the cell wall. There are considerable differences in
cellulose microfibril structure between the various algae species caused by differences in the
biosynthesis process. Most cellulose microfibril researchers have used various species of green
algae. Bacterial cellulose (BC) is a glucose polymer produced through bacterial fermentation.
This macromolecular polymer features the same molecular formula and properties of natural
cellulose. A fiber bundle of 40 to 60 nm thick is formed by micro-fibers with a diameter range
of 3 to 4 nm. These bundles aggregate randomly to produce a developed structure forming a
typical type of nanobiomaterial [42].
Cellulose derivatives and composites offer an excellent biocompatibility, and are considered
as promising materials for biochemical engineering for economic and scientific reasons.
• Oxidized cellulose (oxycellulose) is cellulose in which some of the terminal primary alcohol
groups of the glucose residues have been converted to carboxyl groups. Therefore, the
product is possibly a synthetic polyanhydrocellobiuronide and that contain 25% carboxyl
groups are too brittle and too readily soluble to be of use. Those products that have lower
carboxyl contents are the most desirable[43].
• Purified microcrystalline cellulose (MCC) is partially depolymerized cellulose prepared by
treating α-cellulose, obtained as a pulp from fibrous plant material, with mineral acids.
Silicified MCC (SMCC) is manufactured by codrying a suspension of MCC particles and
colloidal silicon dioxide such that the dried finished product contains 2% colloidal silicon
dioxide. SMCC shows higher bulk density than the common types of MCC. Also, tensile
strength of compacts of SMCC is greater than that of the respective MCC and it is most
probably a consequence of intersurface interactions of silicon dioxide and MCC [44].
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• The esterification can be considered as a typical equilibrium reaction in which an alcohol
and acid react to form ester and water. Cellulose is esterified with certain acids such as acetic
acid, nitric acid, sulfuric acid, and phosphoric acid. A prerequisite is that the acid used can
bring about a strong swelling thus penetrating throughout the cellulose structure. Cellulose
acetate phthalate is a partial acetate ester of cellulose that has been reacted with phthalic
anhydride. One carboxyl of the phthalic acid is esterified with the cellulose acetate. The
finished product contains about 20% acetyl groups and about 35% phthalyl groups [45].
3.1.2. Preparation
The treatments for wood and plants involve the complete or partial removal of matrix materials
(hemicellulose, lignin, etc.) and the isolation of individual complete fibers. Fortunicate the
treatment involves the isolation of the mantel from the animal and the isolation of individual
cellulose fibrils with the removal of the protein matrix. Treatments for algal cellulose sources
typically involve culturing methods, and then purifying steps for removal of algal wall matrix
material. Bacterial cellulose treatments focus on culturing methods for cellulose microfibrillar
growth and then washing to remove the bacteria and other media.
The general processing of engineered BC materials can be considered to occur in four main
stages: (1) BC culturing, (2) pellicle management, (3) water removal, and (4) chemical
modification. For stage 1, the biosynthesis of BC occurs in culture solutions, generally in a
bioreactor, in which bacteria secrete cellulose microfibrils, producing an interwoven web of
fibrils that is a hydrogel. The hydrogels are composed of entangled cellulose microfibrils
formed from the random motion of the bacteria, contain upwards of 99% water, and are called
pellicles. For stage 2, pellicle management refers to any process imparted on the pellicle up
until the point of water removal. To remove the bacteria from the pellicles, the pellicles are
washed by boiling in a low concentration (2%) NaOH bath for several hours, then it is rinsed
under running water for several days. Additional NaOH and NaClO treatments have also been
used for further purification of the BC microfibrils. For stage 3, once the pellicle is formed and
purified, a sample is cut from the gel-like sheet. Water removal either by evaporation or a
combination of pressing and evaporation collapses the gel-network and produces a dense film.
For stage 4, chemical modification to the BC microfibril network can be achieved at three points
along the engineered BC material processing, (i) during stage 1, (ii) during stage 2, and (iii)
after stage 3 (i.e. to dried BC structures or films) [42].
3.1.3. Application
Cellulose is extensively used as a raw material in the paper industry in the production of
paper and cardboard products. However, cellulose has shown its versatility in numerous
applications.
Natural cellulose spheres are often applied in bioseparation, immobilized reaction, cell
suspension culture, and as an adsorbent for sewage treatment. Spherical BC produced from
dynamic method is translucent, loose, porous, and has a hydrophilic network structure. Its
specific surface area increases with decreasing spherical diameter, so it could be used as a
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carrier to adsorb or crosslink various kinds of substances (e.g., enzyme, cell, protein, nucleic
acid, and other compounds). Spherical BC may be applied in bioseparation, immobilized
reaction, cell suspension culture, and as an adsorbent for sewage treatment. Compared with
natural spherical cellulose, the fermentation production of BC spheres is simple, controllable
and environment friendly. Moreover, BC sphere can be used repeatedly, expanding their
potential applications.
Cellulosic derivatives such as cellulose acetate, cellulose propionate and cellulose acetate-
butyrate, cast as membranes, have been reported as useful supports for immobilizing various
enzymes such as catalase, alcohol oxidase and glucose oxidase. These supports gave better
activity and storage stability for the enzymes. Cellulose ethers are widely used as important
excipients for designing matrix tablets. On contact with water, the cellulose ethers start to swell
and the hydrogel layer starts to grow around the dry core of the tablet. The hydrogel presents
a diffusional barrier for water molecules penetrating into the polymer matrix and the drug
molecules being released. Cellulose acetate butyrate microcapsules, as well as cellulose-based
microspheres, have been used for the delivery of drugs [46].
Microbial cellulose synthesized by Acetobacter xylinum shows considerable potential as a novel
wound healing system, resulting from its unique nanostructure. During the process of
biosynthesis, various carbon compounds of the nutrition medium are utilized by the bacteria,
then polymerized into single, linear β-1,4-glucan chains and finally secreted outside the cells
through a linear row of pores located on their outer membrane. Cellulose derived from
Acetobacter xylinum, as discussed above in the context of wound healing, has also been explored
as a potential scaffold material, due to its unusual material properties and degradability.
Moreover, bacterial cellulose derived from Acetobacter xylinum has an ultrafine network
architecture, high hydrophilicity, and mouldability during formation. In addition to the
applications discussed, it is also suitable for use in micronerve surgery and as an artificial blood
vessel suitable for microsurgery [47].
3.2. Chitin-Chitosan
3.2.1. Structure
Chitin is a white, hard, inelastic, nitrogenous polysaccharide found in the exoskeleton as well
as in the internal structure of invertebrates. Chitin is a hydrophobic linear polysaccharide
derived from many natural sources including the exoskeleton of arthropods and insects and
is the second most abundant natural polysaccharide next to cellulose. Chitin comprises a
polysaccharide consisting of (1→4)-β-N-acetyl-D-glucosamine units. Derivatives of chitin may
be classified into two categories; in each case, the N-acetyl groups are removed, and the
exposed amino function then reacts either with acyl chlorides or anhydrides to give the group
NHCOR or is modified by reductive amination to NHCH2COOH of greatest potential
importance are derivatives of both types formed by reaction with bi or polyfunctional reagents,
thus carrying sites for further chemical reaction [48]. In practice, such reactions are carried out
on native chitin or on incompletely deacetylated chitin, chitosan, so that the resulting polymer
contains three types of monomeric units.
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Chitosan is a partially deacetylated derivative of chitin and is the second most abundant
biosynthesized material. Structurally, chitosan is a mixture of N-acetyl-D-glucosamine and D-
glucosamine [49]. Generally, chitosan is insoluble in neutral or basic conditions, while
protonation of free amino groups facilitates solubility of chitosan in dilute acids (pH < 6). In
vivo degradation of chitosan is mainly attributed to the effect of lysozyme through hydrolysis
of acetylated residues.
Chitosan itself chelates metal ions, especially those of transition metals, and also finds
application as a matrix for immobilization of enzymes. Special attention has been given to the
chemical modification of chitin, since it has the greatest potential to be fully exploited.
Reactions with pure chitin have been carried out mostly in the solid state owing to the lack of
solubility in ordinary solvents. A 50% deacetylated chitin has been found to be soluble in water
[50]. This water soluble form of chitin is a useful starting material for its smooth modifications,
through various reactions in solution phase. Some of the very recently reported chitosan
derivatives are enumerated as follows:
• Fully deacetylated chitosan was treated with phthalic anhydride to give N-phthaloyl-
chitosan. It was readily soluble in polar organic solvents. Further reactions had been carried
out using this new derivative to improve the solubility of chitosan [51].
• To improve water solubility, Sashiwa et al. has successfully synthesized dendronized
chitosan-sialic acid hybrids by using gallic acid as focal point and tri(ethylene glycol) as
spacer arm. The water solubility of these novel derivatives was further improved by N-
succinylation of the remaining amine functionality [52].
• Recently, Baba et al. have synthesized methylthiocarbamoyl and phenylthiocarbamoyl
chitosan derivatives to examine the selectivity toward metal ions from aqueous ammonium
nitrate solution [53].
• The synthesis of chitosan hydrogels was carried out by Qu et al. by direct grafting of D,L-
lactic and/or glycolic acid onto chitosan in the absence of catalysts. They demonstrated that
a stronger interaction existed between water and chitosan chains after grafting lactic
and/or glycolic acid. The side chains could aggregate and form physical crosslinking, which
results in pH sensitive chitosan hydrogels [54].
3.2.2. Preparation
Chitin is easily obtained from crab or shrimp shells and fungal. In the first case, chitin pro‐
duction is associated with food industries such as shrimp canning. In the second case, the
production of chitosan–glucan complexes is associated with fermentation processes, similar
to those for the production of citric acid from Aspergillus niger, Mucor rouxii, and Streptomy‐
ces, which involves alkali treatment yielding chitosan–glucan complexes. The alkali removes
the protein and deacetylates chitin simultaneously. Depending on the alkali concentration,
some soluble glycans are removed. The processing of crustacean shells mainly involves the
removal of proteins and the dissolution of calcium carbonate which is present in crab shells in
high concentrations. The resulting chitin is deacetylated in 40% sodium hydroxide at 1200C for
1–3 h. This treatment produces 70% deacetylated chitosan [55].
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3.2.3. Application
Chitin and chitosan are known for their excellent biological properties, among which the
biocompatibility with human cells, the ordered regeneration of wounded tissues, the immu‐
noenhancing activity, the induction of immediate hemostasis, the radical scavenging activity,
and the antimicrobial activity. Recent studies indicate that chitin and chitosan are most
versatile in drug and gene delivery, elaborated diagnostics, devices for selective recognition
of tumor cells, and surgical aids ranging from anti-adhesion gels to coated sterile stents.
As a kind of renewable resource, unmodified chitosan has been widely used in many fields
such as pharmaceutical, agriculture, food, and biomedical applications. In order to realize the
full potential of chitosan and bring a breakthrough in its broader utilization, attempts have
been made to modify chitosan to obtain various derivatives. For the tissue repair and regen‐
eration applications, chitosan can be functionalized by chemical reaction, coupling with
specific ligands or moieties, combining with biomacromolecules, and crosslinking in the
presence or absence of crosslinkers.
Particularly, skin substitute made of chitosan or its derivatives have attracted much attention
due to the outstanding characteristics of chitosan, such as biocompatibility, hemostatic activity,
antibacterial property, and ability to accelerate the wound-healing process [56].
The design of artificial kidney systems has made possible repetitive hemodialysis and the
sustaining life of chronic kidney failure patients. Chitosan membranes have been proposed as
an artificial kidney membrane because of their suitable permeability and high tensile strength.
The most important part of artificial kidney is the semipermeable membrane and so far made
from commercial regenerated cellulose and cuprophane. Since the primary action of the
cellulose membrane is that of a sieve, there is little selectivity in the separation of two closely
related molecules. These novel membranes need to be developed for better control of transport,
ease of formability and inherent blood compatibility.
A series of membranes prepared from chitin and its derivatives improved dialysis properties.
One of the most serious problems of using these artificial membranes is surface induced
thrombosis, where heparization of blood is needed to prevent clotting, and people who are
liable to internal hemorrhage can be dialysed only at great risk. Hence, these are the most
challenging problem still to be resolved in the development of membranes which are inher‐
ently blood compatible. From these point of views, chitosan is hemostatic, i.e., causes clots [57].
Chitosan has replaced the synthetic polymers in opthalmological applications. Chitosan
possesses all the characteristics required for an ideal contact lens; optical clarity, mechanical
stability, sufficient optical correction, gas permeability, partially towards oxygen, wettability,
and immunologically compatibility. Contact lenses are made from partially depolymerized
and purified squid pen chitosan by spin casting technology, and these contact lenses are clear,
tough, and possess other required physical properties such as modulus, tensile strength, tear
strength, elongation, water content, and oxygen permeability. Antimicrobial and wound
healing properties of chitosan along with excellent film forming capability make chitosan
suitable for development of ocular bandage lens [58].
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The special attention on chitosan has been paid for the repair of articular cartilage. Articular
cartilage is particularly vulnerable to injury trama, disease or congenital abnormalities because
of its avascular, alypmhatic and aneural nature. Once damaged, it has little capacity for
intrinsic repair. Although many repair techniques have been attempted over the past four
decades, but none has succeeded to regenerate long-lasting hyaline cartilage tissue to replace
defected or damaged cartilage. Recently, preliminary studies on chitosan-GAG composite and
its biologically interaction with articular chondrocytes showed promising results. Chitosan
and its derivatives are being extensively used for bone tissue engineering and central nervous
system also.
The growth of Escherichia coli was inhibited in the presence of chitosan. Chitosan also inhibited
the growth of Fusarium, Alternaria and Helminthosporium. The cationic amino groups of chitosan
probably bind to anionic groups of these microorganisms, resulting in growth inhibition.
Extracellular lysozyme activity was enhanced in in vitro cultures of several mammalian cells
by treatment with chitin and its derivatives. As a result, connective tissue formation was
stimulated, and the self-defence function against microbial infection was enhanced at the
cellular level. On the basis of these results, several chitin and chitosan dressing materials have
been developed commercially for the healing treatment of human and animal wounds [59].
Chitosan is non-toxic and easily bioabsorbable with gel-forming ability at low pH. Moreover,
chitosan has antacid and antiulcer activities which prevent or weaken drug irritation in the
stomach. Also, chitosan matrix formulations appear to float and gradually swell in an acid
medium. All these interesting properties of chitosan make this natural polymer an ideal
candidate for controlled drug release formulations [60].
4. Decellularization
Autologous  grafts  are  “gold  standard”  for  implantation.  However,  the  most  disadvant‐
age of autologous is quantity. The number of autograft does not meet needs of patients.
Homograft is greater than autograft but they cannot satisfy needs of patient. Many patients
must wait for a long time to take a homogenous organ. Xenograft is the greatest but they
can evoke serious immune reaction. So, one method developed to process homograft and
xenograft is decellularization. Every tissue/organ concludes cells and extracellular matrix.
Cells are structure and functional units of tissue/organ but cells are major antigen of tissue/
organ. Extracellular matrix is many protein, polysaccharide, protoglycan released by cell.
ECM plays an important role in mechanical support,  signal transportation, adherence of
tissue/organ. Decellularization is a multi-step process to remove all cell components from
tissue/organ and leave intact ECM. Many decellularization agents were researched such as
physical methods, chemical methods and enzyme methods. Every decellularization agent
has specific  affections of  cell  and extracellular  matrix.  So,  these agents  are  combined to
make an effective decellularization process which removes all cell components and reverses
maximum ECM. Decellularization effectiveness depends on type of tissue/organ. One agent
can  be  a  good  detergent  for  decellularizing  one  tissue  but  not  for  another  [61].  More‐
over, cell derived ECM can be used as a matrix for cell culture.
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Method Mode of action Effects on ECM
Physical
Snap freezing Intracellular ice crystals disrupt cellmembrane ECM can be disrupted or fracture during rapid freezing
Mechanical force Pressure can burst cells and tissue removaleliminates cells Mechanical force can cause damage to ECM
Mechanical agitation
Can cause cell lysis, but more commonly
used to facilitate chemical exposure and
cellular material removal
Aggressive agitation or sonication can disrupt ECM as the
cellular material is removed
Chemical
Alkaline; acid Solubilize cytoplasmic components of cells;disrupts nucleic acids Removes GAGs
Non-ionic detergents
Triton X-100
Disrupts lipid–lipid and lipid–protein
interactions, while leaving protein –
protein interactions intact
Mixed results; efficiency dependent on tissue, removes GAGs
Ionic detergents
Sodium dodecyl sulfate
(SDS)
Solubilize cytoplasmic and nuclear cellular
membranes; tend to denature proteins
Removes nuclear remnants and cytoplasmic proteins; tends
to disrupt native tissue structure, remove GAGs and damage
collagen
Sodium deoxycholate More disruptive to tissue structure than SDS
Triton X-200 Yielded efficient cell removal when used with zwitterionicdetergents
Zwitterionic detergents
CHAPS Exhibit properties of non-ionic and ionicdetergents
Efficient cell removal with ECM disruption similar to that of
Triton X-100
Sulfobetaine-10 and -16
(SB-10, SB-16)
Yielded cell removal and mild ECM disruption with Triton
X-200
Tri(n-butyl)phosphate Organic solvent that disrupts protein–protein interactions
Variable cell removal; loss of collagen content, although
effect on mechanical properties was minimal
Hypotonic and
hypertonic solutions Cell lysis by osmotic shock
Efficient for cell lysis, but does not effectively remove the
cellular remnants
EDTA, EGTA
Chelating agents that bind divalent
metallic ions, thereby disrupting cell
adhesion to ECM
No isolated exposure, typically used with
enzymatic methods (e.g., trypsin)
Enzymatic
Trypsin Cleaves peptide bonds on the C-side of Argand Lys
Prolonged exposure can disrupt ECM structure, removes
laminin, fibronectin, elastin, and GAGs
Endonucleases
Catalyze the hydrolysis of the interior
bonds of ribonucleotide and
deoxyribonucleotide chains
Difficult to remove from the tissue and could invoke an
immune response
Exonucleases
Catalyze the hydrolysis of the terminal
bonds of ribonucleotide and
deoxyribonucleotide chains
Table 1. Overview of decellularization methods (Thomas W. Gilbert)
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Today, many decellularization grafts were applied in clinical treatment such as acellular valve,
vascular and some are commercial include: SurgisSIS (porcine small intestinal submicosa),
Alloderm (human dermis), ACell (porcine urinary bladder)… Small intestine contains four
layers such as mucosa, submucosa, muscularis externa and serosa. Small intestine submucosa
(SIS) is a submucosa tissue between mucosa and muscularis externa. SIS is isolated from small
intestine by mechanically removing of internal mucosal layer and outer muscular layer. Then,
SIS is processed step-by-step with 0.1% peracid acid, 0.05% gentamycin and sterilized using
2500 kRad gamma irradiation. SIS is consisted of collagen, proteoglycan, glycosaminoglycan,
glycoprotein and growth factor (VEGF, FGF-2 …). Most of these components can be preserved
in extracellular matrix after decellularizing. In tissue engineering, SIS is used as soft tissue
grafts such as vascular, skin or used for reconstructing genitourinary, ligament tissue [62].
4.1. Vascular tissue engineering
Atherosclerosis is the most dangerous cardiovascular disease. Atherosclerosis is a condition
in which vascular wall is harden, thicken because of fatty lipid accumulation. Atherosclerosis
is responsible for millions of death all the world every year. In 2004, seventeen million people
passed away because of cardiovascular disease all over the world (29% world total death).
More than 7 million people are killed by coronary disease (9.6% world total death) (WHO).
Heart American Association, in 2006, coronary disease was responsible for 17.6% death in
America. One out of six American died for coronary disease [63].
Today, there are some methods to cure atherosclerosis including drug treatment, coronary
artery bypass surgery and angioplasty. However, these methods can not cure this condition
completely. More than 30% patients don’t have qualified autogenous vascular grafts. There‐
fore, artificial grafts are made to overcome some current drawbacks.
Artifical graft can be classified into synthetic and biologic scaffold. Synthetic scaffolds include
undegradable polymers such as Dacron, ePTFE and degradable polymers such as polylactic
acid (PLA) and polyglycolic acid (PGA). Some advantages of synthetic polymers are easy
processing, high initial strength, however, they have some disadvantages such as slow
recellularization, poor ability to support remodeling. Biologic vascular grafts are either
obtained by manipulating native proteins of vascular vessels such as collagen, elastin… or by
decellularizing vascular vessels. Decellularized native vascular vessels have some advantages
such as slow cost, reduction of graft rejection and immune reaction [64].
In the early time, decellularization studies were tested without cell-seeding. In 1990, Lantz et
al use SIS (small intestine submucosa) as small-diameter arterial graft in18 dogs. 48 weeks after
surgery, 28 vascular grafts (75%) were patent and tree dogs can survive from 76 to 82 weeks
after implantation. This result suggested that small intestinal submucosa can be used in small
diameter vascular tissue engineering [65]. In 2001, Hodde et al demonstrated that porcine SIS
ECM extract containing vascular endothelial growth factor (VEGF) with concentration of 0.77
ng VEGF/g SIS [66]. In the same year, Nemcova et al isolated and decellularized SIS from
bovine and porcine. Nine decellularized SIS grafts were implanted into femoral arteries of five
male mongrel dogs. After 9 weeks, eight grafts remained patent and some kinds of cell such
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as endothelial cells (ECs), smooth muscle cells (SMCs) invaded into the grafts. No evidence of
inflammatory and aneurysmal symptom was observed during the experimental time [67].
However, the main disadvantage of vascular graft is thrombus which ussually occurs imme‐
diately in vascular graft lumen after implantation. This process can lead to graft failure and
threaten patients’ survival. In order to solve this problem, ECs are used as anti-thrombus agent
in vascular graft lumen, additionally, SMCs are used to improve mechanical strength of
vascular graft. Broschel et al decellularized and recellularized rat iliac arterial grafts. Iliac
arterial grafts were decellualrized by glycerin, SDS for 12 hours. Then, decellularized iliac
grafts were recellularized with adult rat heart ECs and implanted to femoral arteries of
allogeneic rats without systemic anticoagulation injection. After 4 weeks, 2 of 7 control grafts
(29%) were patent (decellularized grafts without recellularization) and 8 of 9 (89%) experi‐
mental grafts (decellularized grafts with recellularization) maintained blood vessel patent [68].
Consequently, this experiment result proved excellent function of ECs in vascular tissue
engineering. Some researchers on vascular tissue engineering seeded autologous vascular cells
including ECs, SMCs and fibroblasts to make autologous tissue engineered vascular. At the
same time, the appearance of bioreactor systems sped up development of vascular tissue
engineering. Niklason developed a pulsatile perfusion bioreactor system in 2001. Bioreactor
contained a stirbar, a lid for gas exchange and one (or two) silicone tubing(s). Porous vascular
scaffolds were threaded over silicone tubing. Bovine aortic SMCs at the passage 2 or 3 were
pipetted onto the outer surface of the scaffolds, then bioreactors were slowly rotated and
removed to incubator with 10% CO2, 100% humidity, and 37oC. Each silicone tubing was linked
to a pulsatile perfusion system operated at 165 beats/minute and 260/-30 mmHg. After 8 weeks
culture, under nonpulsatile condition, SMC growth was on the outer surface of tubing scaffold
and poorly organized. Under pulsatile condition, SMC distribute homogenously in scaffold
wall from outer to inner similar to native structure [69].
Nowaday, some decellularized vascular grafts can be obtained from human. Human umbilical
veins and arteries can be used in decellularization experiment. Human umbilical arteries were
isolated and completely decellularized by Gui et al in 2009. Decellularized umbilical arteries
preserved intact collagen matrix and mechanical properties, burst pressure had no signicant
change from native form. Decellularized artery graft remained patent after 8 weeks surgery
[70]. In 2005, Joel Daniel et al processed human umbilical vein by automated dissection. Human
umbilical cord was inserted a mandrel into vein and frozen to -20 and -80oC, human umbilical
cord was maintained for 12 hours at least at this temperature. The mandrel was lathed with
rotation speed of 2900 rpm, cutting depth of 750 μm. Then, human umbilical vein was
decellularized with 1% (w/v) SDS. The result showed that the treated human umbilical vein
contained no cell; burst pressure results were 972.8 ± 133.8 mmHg (972/1082), compliance
results were 5.7 ± 1.3% over 80 – 120 mmHg. Vascular smooth muscle cells can adhere,
proliferate and migrate on the surface of dHUV [71]. Tran Le Bao Ha et al carried out a research
on decellularization method for HUVs. HUVs were isolated by manual dissection. HUVs were
decellularized by distilled water or NaCl 3M or SDS 1%. The result confirmed that the
combination between SDS 1% (24h) and NaCl 3M (24h) showed the best effective on cellular
elimination.
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 a b 
Figure 6. Human umbilical cord (a) and human umbilical vien (b)
 
a b c 
d e f 
Figure 7. HE staining of HUV with different decellularization methods. Control (a), distilled water (b), NaCl 3M (c), SDS
1% 24h (d), SDS 1% 36h (e), SDS 1% 24. and NaCl 3M 24h (f)
4.2. ECM from cultured cells
One of the most important properties of ECM is its functional diversity. ECM has been reported
to support and enhance for adhesion, migration, proliferation of cells as well as to create stem
cell niches in vitro.. ECM can be harvested from different sources, one of which is from cells
under culture condition. When cultured, cells will produce three-dimensional matrix sur‐
rounding themselves. A method is described for generating tissue culture surfaces coated with
a human fibroblast-derived ECM [72, 73, 74, 75].
For this purpose, human foreskin fibroblasts are isolated, plated and cultured until third
passage (see Figure 8). Fibroblasts are maintained in culture medium until reaching 80%
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confluency and stimulated to synthesize ECM by culture medium supplemented ascorbic acid.
Matrices are denuded of cells and cellular remnants are removed by using Triton X-100,
NH4OH and DNase.
Then, ECM coated culture surfaces are tested by staining with PI to access DNA remnant (see
Figure 9), with H&E and PAS in order to characterize component of ECM. The results suggest
that fibroblast-derived three-dimensional matrix was determined to be free of cellular
constituents and still remain attached to the culture surface. The conducted matrices were
washed and covered with PBS; and stored at 40C. Under these conditions, biological activity
(for example, induction of cell attachment, proliferation…) was reported to be well-preserved
for up to 6 months.
In order to evaluate the quality of the ECM, the test of cell rapid attachment ability is per‐
formed. Cell proliferation on ECM is also assessed. Results showed that the cultured cells
attached and proliferated on ECM coated surfaces faster than on ECM non-coated surfaces.
 
a b 
Figure 8. Fibroblasts are in cultured surfaces (a) and are stimulated to synthesize ECM (b)
 
b a 
Figure 9. ECM stained PI before (a) and after (b) using DNase
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 a b 
Figure 10. Culture surface before (a) and after (b) is denuded cells
5. Conclusion
In modern society, many diseases have been increasing in human because of pollution, accident,
lifestyle...  The mutilation in human body leads to expand the needs of replacing tissues/
organs. However, the available source of tissues/organs is limited. Creating artificial tissues/
organs for replacing damaged, dysfunctional tissues/organs becomes a big discipline on material
science. Naturally derived biomaterials have been studied and applied in clinical applications
as artificial tissues/organs because they are capable of supporting cell proliferation, biodegrad‐
ability and remodeling tissues. Although the current results have not completely satisfy the
clinical demand, the potential applications of naturally derived biomaterials are still highly
considered, therefore, research on this field have now being taken place all over the world.
Author details
Tran Le Bao Ha*, To Minh Quan, Doan Nguyen Vu and Do Minh Si
*Address all correspondence to: tlbha@hcmus.edu.vn
University of Science, Vietnam National University – Hochiminh city, Vietnam
References
[1] Lodish, H, Berk, A, & Zipursky, S. L. Molecular Cell Biology. New York: W. H. Free‐
man (2000).
Naturally Derived Biomaterials: Preparation and Application
http://dx.doi.org/10.5772/55668
269
[2] Anu, M. Type XV collagen. University of Oulu (2001).
[3] Hassan, N, Habibollah, P, & Abolhassan, A. Properties of the amniotic membrane for
potential use in tissue engineering. European cells & materials (2008). , 15, 88-89.
[4] Andrew, H, Vijay, A. S, Trevor, G, Aaron, M. Y, James, L, David, K. J, & Harminder,
S. D. Optimization of amniotic membrane (AM) denuding for tissue engineering. Tis‐
sue engineering (2008). , 14, 371-383.
[5] Singh, R, Purohit, S, & Chacharkar, M. P. Effect of high doses of gamma radiation on
the functional characteristics of amniotic membrane. Radiation Physics and Chemis‐
try (2007). , 76, 1026-1030.
[6] Loss, M, Wedler, V, Kunzi, W, Meuli-simmen, C, & Meyer, V. E. Artificial skin, split-
thickness autograft and cultured autologous keratinocytes combined to treat a severe
burn injury of 93% of TBSA. Burns (2000). , 26, 644-652.
[7] Ludwik, K. B, David, N. H, Mario, M. C, William, B. N, Oscar, E. M, & Marc, G. J.
Amnion in the treatment of pediatric partial-thickness facial burns. Burns (2008). , 34,
393-399.
[8] Susan, S. Y. Current Protocols in Cell Biology. John Wiley & Sons, Inc. (2003). , 1-2.
[9] Rose, P. J, Mark, H. F, Bikales, N. M, Overberger, C. G, Menges, G, & Kroschwitz, J. I.
editors. Encyclopedia of polymer science and engineering. New York, USA: Wiley
(1989). , 488-513.
[10] Draget, K. I, Smidsrod, O, & Skjàk-bræk, G. Alginate from algae. In Polysaccharide
and Polyamides in the food Industry. In: Steinbüchel A, Rhee SK. (eds). Wiley-VCH
Verlag GmbH & Co.: Weinheim (2005). , 1-30.
[11] Ertesvåg, H, Valla, S, & Skjåk-bræk, G. Genetics and biosynthesis of alginates. Carbo‐
hyd. Europe (1996). , 14, 14-18.
[12] Paul, W, & Sharma, C. P. Chitosan and Alginate Wound Dressings: A Short Review.
Trends in Biomaterials and Artificial Organs (2004). , 18, 18-23.
[13] Chen, J. P, Chu, I. M, Shiao, M. Y, Hsu, B. R, & Fu, S. H. Microencapsulation of islets
in PEG amine modified alginate-poly(l-lysine)-alginate microcapsules for construct‐
ing bioartificial pancreas. Journal of Fermentation and Bioengineering (1998). , 86,
185-190.
[14] Rowley, J. A, Madlambayan, G, & Mooney, D. J. Alginate hydrogels as synthetic ex‐
tracellular matrix materials. Biomaterials (1999). , 20, 45-53.
[15] Seifert, D. B, & Phillips, J. A. Porous alginate-poly(ethylene glycol) entrapment sys‐
tem for the cultivation of mammalian cells. Biotechnology progress (1997). , 13,
569-576.
[16] Altman, G. H. Silk-based biomaterials. Biomaterials (2003). , 24, 401-416.
Regenerative Medicine and Tissue Engineering270
[17] Tanaka, K, Inoue, S, & Mizuno, S. Hydrophobic interaction of containing Asn-linked
oligosaccharide chains, with the H-L complex of silk fibroin produced by B. mori. In‐
sect Biochemistry and Molecular Biology (1999). , 25.
[18] Inoue, S. Silk fibroin of Bombyx mori is secreted, assembling a high molecular mass
elementary unit consisting of H-chain, L-chain, and with a 6:6:1 molar ratio. Journal
of Biological Chemistry (2000). , 25.
[19] Seidel, A. Regenerated spider silk: Processing, properties, and structure. Macromole‐
cules (2000). , 33, 775-780.
[20] Xu, M. Structure of a protein superfiber: spider dragline silk. Proceedings of the Na‐
tional Academy of Sciences of the United States of America (1990). , 87, 7120-7124.
[21] Kumaresan, P. Sericin a versatile by product. Indian Silk (2007). , 45, 11-13.
[22] Dandin, S. B. Biomedical uses of silk and its derivatives. Indian Silk (2007). , 45, 5-8.
[23] Gulrajani, M. L. Sericin-a bio-molecule of value. Indian Silk (2006). , 45, 16-22.
[24] Wang, Y. Cartilage tissue engineering with silk scaffolds and human articular chon‐
drocytes. Biomaterials (2006). , 27, 4434-4442.
[25] Sofia, S. Functionalized silk-based biomaterials for bone formation. Journal of Bio‐
medical Materials Research (2001). , 54, 139-148.
[26] Megeed, Z. Genetically engineered silk-elastinlike protein polymers for controlled
drug delivery. Advanced drug delivery reviews (2002). , 54, 1075-1091.
[27] Medved, L. V, Gorkun, O. V, & Privalov, P. L. Structural organiza-tion of C-terminal
parts of fibrinogen A alpha-chains. FEBS Lett (1983). , 160, 291-295.
[28] Ferry, J. D, & Morrison, P. R. Preparation and properties of serum and plasma pro‐
teins. VIII. The conversion of human fibrinogen to fibrin under various conditions.
Journal of the American Chemical Society (1947). , 69, 388-400.
[29] Betts, L, Merenbloom, B. K, & Lord, S. T. The structure of fibrinogen fragment D with
the ‘A’ knob peptide GPRVVE. Journal of Thrombosis and Haemostasis (2006). , 4,
1139-1141.
[30] Ryan, E. A, Mockros, L. F, Stern, A. M, & Lorand, L. Influence of a natural and a syn‐
thetic inhibitor of factor XIIIa on fibrin clot rheology. Biophysical Journal (1999). , 77,
2827-2836.
[31] Collet, J. P, Shuman, H, Ledger, R. E, Lee, S, & Weisel, J. W. The elasticity of an indi‐
vidual fibrin fiber in a clot. Proceedings of the National Academy of Sciences of the
United States of America (2005). , 102, 9133-9137.
[32] Kaitlin, C, & Murphy, J. Kent Leach. A reproducible, high throughput method for
fabricating fibrin gels. BMC Research Notes (2012).
Naturally Derived Biomaterials: Preparation and Application
http://dx.doi.org/10.5772/55668
271
[33] Bensaïd, W, Triffitt, J. T, Blanchat, C, Oudina, K, Sedel, L, & Petite, H. A biodegrada‐
ble fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials (2003). ,
24, 2497-2502.
[34] Okada, M, & Blomback, B. Calcium and fibrin gel structure. Thrombosis Research
(1983). , 29, 269-280.
[35] Siebenlist, K. R, & Mosesson, M. W. Progressive cross-linking of fibrin gamma chains
increases resistance to fibrinolysis. Journal of Biological Chemistry (1994). , 269,
28414-28419.
[36] Alan, R. H, Dennis, K. G, Mark, P. H, Frank, C. S, & Constantine, E. Autologous
Whole Plasma Fibrin Gel: Intraoperative Procurement. Archieves of Surgery (1992). ,
127, 357-359.
[37] Ye, Q, Zünd, G, & Benedikt, P. Fibrin gel as a three dimensional matrix in cardiovas‐
cular tissue engineering. European Journal of Cardio-thoracic Surgery (2000). , 17,
587-591.
[38] Bensa, W, Triffittb, J. T, Blanchata, C, Oudinaa, K, Sedela, L, & Petitea, H. A biode‐
gradable fibrin scaffold for mesenchymal stemcell transplantation. Biomaterials
(2003). , 2497-2502.
[39] Saltz, R, Dimick, A, Harris, C, Grotting, J. C, Psillakis, J, & Vasconez, L. O. Applica‐
tion of autologous fibrin glue in burn wounds. Journal of Burn Care & Rehabilitation
(1989). , 10, 504-507.
[40] Klemm, D, Philipp, B, Heinze, T, Heinze, U, & Wagenknecht, W. Comprehensive
Cellulose Chemistry. Fundamentals and Analytical Methods. Wiley-VCH, Weinheim
(1998).
[41] Myasoedova, V. V. Physical chemistry of non-aqueous solutions of cellulose and its
derivatives. John Wiley and Sons, Chirchester (2000).
[42] Robert, J. M, Ashlie, M, John, N, John, S, & Je, Y. Cellulose nanomaterials review:
structure, properties and nanocomposites. Chemical Society Reviews (2011). , 40,
3941-3994.
[43] Nabar, G. M, & Padmanabhan, C V. Studies in oxycellulose. Proceedings of the Indi‐
an Academy of Sciences (1950). , 31, 371-380.
[44] Kibbe, A. H. Handbook of pharmaceutical excipients: Cellulose, silicified microcrys‐
talline. American Public Health Association. Washington (2000).
[45] Wadworth, L. C, & Daponte, D. Cellulose esters. In: Nevell TP, Zeronian SH (ed.)
Cellulose Chemistry and its Applications. Ellis Horwood, Chich-ester (1985). ,
349-362.
[46] Delgado, J. N, & William, A. Wilson and Gisvold’s textbook of organic medicinal and
pharmaceutical chemistry. Lippincott-Raven Publishers, Wickford (1998).
Regenerative Medicine and Tissue Engineering272
[47] Svensson, A, Nicklasson, E, Harrah, T, Panilaitis, B, Kaplan, D, Brittberg, M, & Gate‐
nholm, P. Bacterial Cellulose as a Potential Scaffold for Tissue Engineering of Carti‐
lage. Biomaterials (2005). , 26, 419-431.
[48] Muzzarellieditor. Natural Chelating Polymers. Pergamon Press, New York (1973).
[49] Zikakiseditor. Chitin, Chitosan and Related Enzymes. Academic Press, Orlando
(1984).
[50] Dutta, P. K. Ravikumar MNV, Dutta J. Chitin and chitosan for versatile applications,
Journal of Macromolecular Science-polymer Reviews (2002). , 42, 307-315.
[51] Kurita, K. Chemistry and application of chitin and chitosan, Polymer Degradation
and Stability (1998). , 59, 117-120.
[52] Sashiwa, H, Shigemasa, Y, & Roy, R. Chemical modification of chitosan: synthesis of
dendronized chitosan-sialic acid hybrid using convergent grafting of preassembled
dendrons built on gallic acid and tri(ethylene glycol) backbone. Macromolocules
(2001). , 34, 3905-3920.
[53] Baba, Y, Noma, H, Nakayama, R, & Matsushita, Y. Preparation of chitosan deriva‐
tives containing methylthiocarbamoyl and phenylthiocarbamoyl groups and their se‐
lective adsorption of copper (II) over iron (III). Analytical sciences (2002). , 18,
359-370.
[54] Qu, X, Wirsen, A, & Albertsson, A. C. Effect of lactic/glycolic acid side chains on the
thermal degradation kinetics of chitosan derivatives. Polymer (2001). , 41, 4841-4850.
[55] Madhavan editor. Chitin Chitosan and their Novel Applications. Science Lecture Ser‐
ies, CIFT, Kochi (1992).
[56] Prasitslip, M, Jenwithisuk, R, Kongsuwan, K, Damrongchai, N, & Watts, P. Cellular
responses to chitosan in vitro: the importance of deacetylation, Journal of Materials
Science: Materials in Medicine (2000). , 11, 773-780.
[57] Lin, W. C, Liu, T. Y, & Yang, M. C. Hemocompatibility of polyacrylonitrile dialysis
membrane immobilized with chitosan and heparin conjugate. Biomaterials (2003).
[58] Markey Bowman, Bergamini, editor. Chitin and Chitosan. Elsevier Applied Science,
London (1989).
[59] Gebelein CarraherJr, editor. Industrial Biotechnological Polymers. Technomic, Lan‐
caster (1995).
[60] Uhrich, K. E, Cannizzaro, S. M, Langer, R. L, & Shakesheff, K. M. Polymeric systems
for controlled drug release. Chemical Reviews (1999). , 99, 3181-3190.
[61] Thomas, W. G. Decellularization of tissues and organs, Biomaterials (2006). , 27,
3675-3683.
Naturally Derived Biomaterials: Preparation and Application
http://dx.doi.org/10.5772/55668
273
[62] Jason, H. Naturally Occurring Scaffold for Soft Tissue Repair and Regeneration. Tis‐
sue Engineering (2002). , 8, 295-308.
[63] Véronique, L. R. Heart Disease and Stroke Statistics- (2012). Update: A Report from
the Amercian Heart Association. Circulation 2012.
[64] Chrysanthi, W. Engineering of Small Diamter Vessels.Therapeutic applications: tis‐
sue therapy; , 1000-1013.
[65] Lantz Small Intestinal Submucosa as a Small-Diameter Arterial Graft in the Dog.
Journal of Investigative Surgery (1990). , 3, 217-227.
[66] Hodde, J. P. Vascular endothelial growth factor in porcine-derived extracellular ma‐
trix. Endothelium (2001). , 8, 11-24.
[67] Nemcova, S, Noel, A. A, Jost, C. J, Gloviczki, P, Miller, V. M, & Brockbank, K. G.
Evaluation of a xenogeneic acellular collagen matrix as a small-diameter vascular
graft in dogs preliminary observations. Journal of Investigative Surgery (2001).
[68] Borschel, G. H. Tissue engineering of recellularized small-diameter vascular grafts.
Tissue Engineering (2005). , 11, 778-786.
[69] Laura, E. N. Morphologic and mechanical characteristics of engineered bovine arter‐
ies. Journal of vascular surgery (2001). , 33, 628-638.
[70] Gui, L. Development of decellularized human umbilical arteries as small-diameter
vascular grafts. Tissue Engineering (2009). , 15, 2665-2676.
[71] Joel, D. Development of the Human Umbilical Vein Scaffold for Cardiovascular Tis‐
sue Engineering Applications. ASAIO Journal (2005). , 51, 252-261.
[72] Kenneth, M. Y. Current Protocols in Cell Biology. John Wiley & Sons, Inc. (2003). ,
1-10.
[73] Badylak, S, Gilbert, T, & Irvin, J. The extracellular matrix as a biologic scaffold for tis‐
sue engineering. Tissue Engineering (2008). , 121-144.
[74] Chen, R. N, Ho, H. O, Tsai, Y. T, & Sheu, M. T. Process development of an acellular
dermal matrix (ADM) for biomedical application. Biomaterials (2004). , 25, 2679-2686.
[75] Cheng, Z. J, So, R. P, Byung, H. C, Kwideok, P, & Byoung, H. M. In vivo cartilage tis‐
sue engineering using a cell-derived extracellular matrix scaffold. Artificial Organs
(2007). , 31, 183-192.
Regenerative Medicine and Tissue Engineering274
